Chugai Pharmaceutical Co., Ltd.
Mitsubishi Logistics Corporation

Chugai and Mitsubishi Logistics Enter into Service Agreementfor Logistics Operations

TOKYO, June 14, 2019 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Mitsubishi Logistics Corporation(TOKYO: 9301) announced today that the two companies have signed a service agreement to outsource Chugai’s
logistics operations for its pharmaceutical products to Mitsubishi Logistics. The operation of the distribution
center managed by Mitsubishi Logistics is scheduled to start in January 2021.
Guidelines on Good Distribution Practice (GDP) of Medicinal Products for distribution management ofpharmaceutical products were issued in 2018 to provide methods to ensure quality of pharmaceutical products inthe process of transportation and storage. In addition, companies must address changes in external environment
surrounding distribution management of their products; for example, they have to strengthen Business Continuity
Planning (BCP) to cope with large-scale disasters and take actions to reduce risks in delivery.
As one of the five strategies in “IBI 21,” the company’s mid-term business plan starting from 2019, Chugai has set
a goal of “Strengthen Human Capital and Conduct Fundamental Structural Reform” to review its business process
and cost structure. The company aims to sophisticate and streamline logistics functions with high expertisethrough outsourcing to Mitsubishi Logistics, as an effort to invest in sustainable growth and create a high profit
structure by focusing resources in innovation.
With this agreement, Chugai Distribution Co., Ltd., a wholly owned subsidiary of Chugai which currently
provides logistics operations, will close down its business following the startup of the distribution center managed
by Mitsubishi Logistics.
Mitsubishi Logistics will focus on providing high-quality and efficient pharmaceutical logistics service by further
improving the service level as a company to support stable supply of pharmaceutical products.
About Chugai
Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths inbiotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively
involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products
which may satisfy the unmet medical needs, mainly focusing on the oncology area.
Additional information is available on the internet at https://www.chugai-pharm.co.jp/english/.

About Mitsubishi Logistics
Mitsubishi Logistics is a logistics company supporting supply chains of a wide range of industries, including
pharmaceuticals, food and beverage, and electric appliances, through seamless logistics service such as
warehousing, land transportation, and international transportation. Mitsubishi Logistics has provided high-quality
service in pharmaceutical distribution utilizing expertise accumulated for over 30 years through management ofdistribution centers of a great deal of pharmaceutical companies. For further information on Mitsubishi Logistics,
please visit at https://www.mitsubishi-logistics.co.jp/english/.

###Contact:
Chugai Pharmaceutical Co., Ltd.
Media Relations Group, Corporate Communications Dept.
Tel: +81-3-3273-0881
Email: pr@chugai-pharm.co.jp
Investor Relations Group, Corporate Communications Dept.
Tel: +81-3-3273-0554
Email: ir@chugai-pharm.co.jp

Mitsubishi Logistics Corporation
Corporate Communications Chamber
Tel: +81-3-3278-6652
Email: koho@mitsubishi-logistics.co.jp